Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67026875 | 6702687 | 5 | F | 20080707 | 20160826 | 20080717 | 20160830 | EXP | US-GILEAD-2008-0017240 | GILEAD | 77.00 | YR | E | F | Y | 52.15000 | KG | 20160830 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67026875 | 6702687 | 1 | PS | AMBRISENTAN | AMBRISENTAN | 1 | Unknown | 5 MG, QD | 22081 | 5 | MG | TABLET | QD | ||||||
| 67026875 | 6702687 | 2 | SS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 80 MG, TID | Y | R061117 | 0 | 80 | MG | TID | |||||
| 67026875 | 6702687 | 3 | SS | VIAGRA | SILDENAFIL CITRATE | 1 | Unknown | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 67026875 | 6702687 | 4 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Unknown | 50 ML, QD | 0 | 50 | ML | QD | |||||||
| 67026875 | 6702687 | 5 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 100 MG, QD | 0 | 100 | MG | QD | ||||||||
| 67026875 | 6702687 | 6 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 75 MG, QD | 0 | 75 | MG | QD | ||||||||
| 67026875 | 6702687 | 7 | C | DIGOXIN. | DIGOXIN | 1 | 125 MG, QD | 0 | 125 | MG | QD | ||||||||
| 67026875 | 6702687 | 8 | C | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | 1 DF, QD | 0 | 1 | DF | QD | ||||||||
| 67026875 | 6702687 | 9 | C | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | 2 MG, UNK | 0 | 2 | MG | QD | ||||||||
| 67026875 | 6702687 | 10 | C | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | UNK | Y | 0 | ||||||||||
| 67026875 | 6702687 | 11 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 20 MG, QD | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 67026875 | 6702687 | 1 | Pulmonary arterial hypertension |
| 67026875 | 6702687 | 2 | Pulmonary arterial hypertension |
| 67026875 | 6702687 | 3 | Pulmonary arterial hypertension |
| 67026875 | 6702687 | 4 | Pulmonary arterial hypertension |
| 67026875 | 6702687 | 5 | Pulmonary arterial hypertension |
| 67026875 | 6702687 | 7 | Pulmonary arterial hypertension |
| 67026875 | 6702687 | 8 | Pulmonary arterial hypertension |
| 67026875 | 6702687 | 11 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 67026875 | 6702687 | HO |
| 67026875 | 6702687 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 67026875 | 6702687 | Fall | |
| 67026875 | 6702687 | Hip fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 67026875 | 6702687 | 2 | 2011 | 0 | ||
| 67026875 | 6702687 | 4 | 19950406 | 0 | ||
| 67026875 | 6702687 | 10 | 201503 | 0 |